Skip to main content

Horizons Marijuana Life Sciences ETF(HMMJ-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Horizons Marijuana Life Sciences ETF down on Tuesday (HMMJ)

Automated Summaries - The Globe and Mail - Tue Mar 12, 4:02PM CDT

Today, shares of Horizons Marijuana Life Sciences ETF opened at $8.90 and closed at $8.88. It traded at a low of $8.84 to a high of $8.91.

The price eased -0.11% from the previous day's close of $8.89.

Today across North America, the TSX Composite closed 0.15% at 21769.22, the S&P 500 closed -0.11% at 5117.94, the Dow Jones Industrial Average closed 0.12% at 38769.66 and the Nasdaq Composite closed -0.41% at 16019.27.

Horizons Marijuana Life Sciences ETF traded under HMMJ on the Toronto Stock Exchange (TSX).

Trading volume was 2,258 on 25 total trades, while having an average volume of 6,660 in the last five days.

Trading across the entire TSX saw 2,423 price advancers against 2,825 declines and 120 unchanged.

During the prior 52 weeks, HMMJ.TO has traded as high as $11.61 (September 12,2023) and low as $8.07 (October 27,2023). Moreover, the shares have eased -18.08 percent in the last 52 weeks, while in 2024, they have eased -4.41%.

Following today's trading, Horizons Marijuana Life Sciences ETF has a market capitalization of $74.15 million on a float of 8,341 shares outstanding. Its annual EPS is $None.

Horizons Marijuana Life Sciences ETF is a None company headquartered in, None.

The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry..

Currently, Horizons Marijuana Life Sciences ETF's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe